Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakagami, H.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakagami, H.
Right arrow Articles by Ogihara, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:1472-1481, 2001
© 2001 by the American Diabetes Association, Inc.

Phosphorylation of p38 Mitogen-Activated Protein Kinase Downstream of Bax-Caspase-3 Pathway Leads to Cell Death Induced by High D-Glucose in Human Endothelial Cells

Hironori Nakagami1, Ryuichi Morishita1,2, Kei Yamamoto1, Shin-ichi Yoshimura3, Yoshiaki Taniyama1, Motokuni Aoki1, Hiroaki Matsubara4, Shokei Kim5, Yasufumi Kaneda2, and Toshio Ogihara1

1 Geriatric Medicine and
2 Gene Therapy Science, Osaka University Medical School, Suita
3 Department of Neurosurgery, Gifu University School of Medicine, Gifu
4 Department of Second Internal Medicine, Kansai Medical College, Moriguchi
5 Department of Pharmacology, Osaka City Medical College, Osaka, Japan

Because high D-glucose significantly stimulates endothelial cell death, we examined the molecular mechanisms of high D-glucose–induced endothelial apoptosis. Treatment of human aortic endothelial cells with high D-glucose (25 mmol/l), but not mannitol and L-glucose, resulted in a significant decrease in cell number and a significant increase in apoptotic cells as compared with a physiological concentration (5 mmol/l). Interestingly, high D-glucose treatment significantly increased bax protein, accompanied by translocation of bax protein from cytosol to mitochondria-enriched heavy membrane fraction. In contrast, the expression and distribution of bcl-2 protein were not altered by high D-glucose. In addition, the activity of caspase-3 proteases was increased after exposure to high glucose, whereas caspase inhibitors prevented endothelial cell death induced by high D-glucose. On the other hand, p38 mitogen-activated protein kinase (MAPK) was markedly phosphorylated and showed sustained phosphorylation after stimulation. A specific inhibitor of p38 MAPK, SB 203580, and the overexpression of kinase-inactive p38 MAPK significantly attenuated cell death induced by high D-glucose in human aortic endothelial cells, whereas at 6 h after high D-glucose treatment, SB 203580 and overexpression of kinase-inactive p38 MAPK did not attenuate caspase-3 activation induced by high D-glucose. Importantly, caspase inhibitors significantly attenuated the sustained phosphorylation of p38 MAPK induced by high D-glucose. Thus, we finally focused the MAPK kinase (MEK) kinase 1 (MEKK1) to further examine the cross-talk between p38 MAPK and the bax-caspase proteases pathway. High D-glucose treatment induced MEKK1 cleavage, whereas caspase inhibitors significantly attenuated the cleavage. Importantly, kinase-inactive MEKK1 also blocked the phosphorylation of p38 MAPK induced by high D-glucose. Here, we demonstrated that high D-glucose induced apoptosis in human endothelial cells through activation of the bax-caspase proteases pathway and through phosphorylation of p38 MAPK mediated by MEKK1. Phosphorylation of p38 MAPK downstream of the bax-caspase pathway may play a pivotal role in endothelial apoptosis mediated by high D-glucose.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Takami, H. Nakagami, R. Morishita, T. Katsuya, T.-X. Cui, T. Ichikawa, Y. Saito, H. Hayashi, Y. Kikuchi, T. Nishikawa, et al.
Ubiquitin Carboxyl-Terminal Hydrolase L1, a Novel Deubiquitinating Enzyme in the Vasculature, Attenuates NF-{kappa}B Activation
Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2184 - 2190.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, V. R. Drel, I. G. Obrosova, and P. Pacher
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H610 - H619.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. Li, J. A. Deane, N. V. Campanale, J. F. Bertram, and S. D. Ricardo
Blockade of p38 Mitogen-Activated Protein Kinase and TGF-beta1/Smad Signaling Pathways Rescues Bone Marrow-Derived Peritubular Capillary Endothelial Cells in Adriamycin-Induced Nephrosis
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2799 - 2811.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. B. El-Remessy, M. Al-Shabrawey, Y. Khalifa, N.-T. Tsai, R. B. Caldwell, and G. I. Liou
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
Am. J. Pathol., January 1, 2006; 168(1): 235 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. McMullen, P. W. Bryant, C. C. Glembotski, P. A. Vincent, and K. M. Pumiglia
Activation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells
J. Biol. Chem., June 3, 2005; 280(22): 20995 - 21003.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. L. Sheu, F. M. Ho, R. S. Yang, K. F. Chao, W. W. Lin, S. Y. Lin-Shiau, and S.-H. Liu
High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase-Regulated Cyclooxygenase-2 Pathway
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 539 - 545.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A. B. El-Remessy, M. Bartoli, D. H. Platt, D. Fulton, and R. B. Caldwell
Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration
J. Cell Sci., January 1, 2005; 118(1): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. McGinn, S. Saad, P. Poronnik, and C. A. Pollock
High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E708 - E717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. McGinn, P. Poronnik, M. King, E. D. M. Gallery, and C. A. Pollock
High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity
Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1374 - C1386.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Nakagami, R. Morishita, K. Yamamoto, Y. Taniyama, M. Aoki, K. Yamasaki, K. Matsumoto, T. Nakamura, Y. Kaneda, and T. Ogihara
Hepatocyte Growth Factor Prevents Endothelial Cell Death Through Inhibition of bax Translocation From Cytosol to Mitochondrial Membrane
Diabetes, August 1, 2002; 51(8): 2604 - 2611.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. K. Jain, K. Kannan, G. Lim, R. McVie, and J. A. Bocchini Jr.
Hyperketonemia Increases Tumor Necrosis Factor-{alpha} Secretion in Cultured U937 Monocytes and Type 1 Diabetic Patients and Is Apparently Mediated by Oxidative Stress and cAMP Deficiency
Diabetes, July 1, 2002; 51(7): 2287 - 2293.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Morishita, M. Sakaki, K. Yamamoto, S. Iguchi, M. Aoki, K. Yamasaki, K. Matsumoto, T. Nakamura, R. Lawn, T. Ogihara, et al.
Impairment of Collateral Formation in Lipoprotein(a) Transgenic Mice: Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene
Circulation, March 26, 2002; 105(12): 1491 - 1496.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.